Protalix BioTherapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 3.62 M | $7.85 M | -0.83% | 4.60% |
| MAK CAPITAL ONE LLC | 05/15/2026 | 3.54 M | $7.69 M | 100.00% | 4.51% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 1.22 M | $2.66 M | -3.05% | 1.56% |
| STATE STREET CORP | 05/15/2026 | 972.82 K | $2.11 M | 66.22% | 1.24% |
| NORTHERN TRUST CORP | 05/14/2026 | 885.45 K | $1.92 M | 2.28% | 1.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 865.30 K | $1.88 M | 4.25% | 1.10% |
| STRATOS WEALTH PARTNERS, LTD. | 04/28/2026 | 500.00 K | $1.09 M | 0.00% | 0.64% |
| 05/08/2026 | 432.49 K | $938.49 K | 100.00% | 0.55% | |
| PROSPERA FINANCIAL SERVICES INC | 04/14/2026 | 418.57 K | $908.27 K | 100.00% | 0.53% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 340.00 K | $737.80 K | -86.28% | 0.43% |
| MORGAN STANLEY | 05/15/2026 | 301.79 K | $654.89 K | 128.65% | 0.38% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 296.84 K | $643.79 K | 932.71% | 0.38% |
| UBS GROUP AG | 05/05/2026 | 265.54 K | $576.21 K | 1.15% | 0.34% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 251.35 K | $545.42 K | -4.36% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 219.31 K | $475.90 K | 4.00% | 0.28% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 207.28 K | $449.79 K | -10.69% | 0.26% |
| ROUND ROCK ADVISORS, LLC | 05/15/2026 | 192.08 K | $416.81 K | 23.84% | 0.24% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 189.10 K | $410.35 K | 0.00% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 176.60 K | $383.22 K | 100.00% | 0.22% |
| EVERGREEN CAPITAL MANAGEMENT LLC | 05/14/2026 | 171.34 K | $371.80 K | 0.00% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 159.31 K | $345.71 K | -9.00% | 0.20% |
| DIAMETRIC CAPITAL, LP | 05/15/2026 | 124.20 K | $269.50 K | -10.61% | 0.16% |
| NUVEEN, LLC | 04/30/2026 | 90.19 K | $195.71 K | 0.00% | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 05/15/2026 | 86.62 K | $187.96 K | 21.32% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 79.08 K | $171.60 K | 70.61% | 0.10% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 74.99 K | $162.72 K | 8,763.48% | 0.10% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 67.89 K | $147.00 K | 100.00% | 0.09% |
| ORIN GREEN FINANCIAL, LLC | 04/29/2026 | 64.43 K | $139.82 K | 4.88% | 0.08% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 63.35 K | $137.47 K | 100.00% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 59.70 K | $129.55 K | 100.00% | 0.08% |
| JANE STREET GROUP, LLC | 05/12/2026 | 58.00 K | $125.86 K | 100.00% | 0.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 53.48 K | $117.00 K | 51.59% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 49.09 K | $106.51 K | 27.43% | 0.06% |
| INVESCO LTD. | 05/12/2026 | 47.40 K | $102.86 K | -6.25% | 0.06% |
| RHUMBLINE ADVISERS | 05/12/2026 | 45.82 K | $99.42 K | 3.26% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2026 | 43.70 K | $94.83 K | 58.33% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2026 | 43.70 K | $94.82 K | 100.00% | 0.06% |
| PHOENIX HOLDINGS LTD. | 05/11/2026 | 40.00 K | $86.74 K | 100.00% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2026 | 34.06 K | $73.92 K | 2.45% | 0.04% |
| JANE STREET GROUP, LLC | 05/12/2026 | 31.70 K | $68.79 K | 100.00% | 0.04% |
| JPMORGAN CHASE & CO | 05/13/2026 | 31.69 K | $66.22 K | 2.63% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 05/06/2026 | 31.10 K | $67.49 K | 0.00% | 0.04% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 30.49 K | $66.17 K | 100.00% | 0.04% |
| APTUS CAPITAL ADVISORS, LLC | 05/11/2026 | 27.23 K | $59.09 K | 2.33% | 0.03% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 26.52 K | $57.55 K | -66.43% | 0.03% |
| CAPITAL PERFORMANCE ADVISORS LLP | 05/07/2026 | 26.05 K | $56.53 K | 0.29% | 0.03% |
| SMARTLEAF ASSET MANAGEMENT LLC | 05/15/2026 | 25.98 K | $54.29 K | 0.00% | 0.03% |
| CITADEL ADVISORS LLC | 05/15/2026 | 25.90 K | $56.20 K | 52.35% | 0.03% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 22.67 K | $49.20 K | 100.00% | 0.03% |
| STATE OF ALASKA, DEPARTMENT OF REVENUE | 04/20/2026 | 21.83 K | $47.00 K | 0.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protalix BioTherapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Protalix BioTherapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 3.62 M
MAK CAPITAL ONE LLC: 3.54 M
RENAISSANCE TECHNOLOGIES LLC: 1.22 M
STATE STREET CORP: 972,815
NORTHERN TRUST CORP: 885,448
GEODE CAPITAL MANAGEMENT, LLC: 865,298
21.20% of Protalix BioTherapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.34 M shares in the last 24 months. This purchase volume represents approximately $49.95 M in transactions.